Breckenridge Pharmaceutical, Inc recalls

33 recalls on record

Recalls filed with 1 agency: FDA (33).

First recall on record: November 18, 2015. Most recent: June 17, 2026.

Risk classification: Class II: 31 · Class III: 2

Recalert records 33 recalls for Breckenridge Pharmaceutical, Inc from FDA. The earliest is dated November 18, 2015 and the latest June 17, 2026. 5 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Duloxetine Delayed-Release Capsules, USP, 60mg, packaged in a) 90 Capsules (NDC 51991-748-90); b) 1000 Capsules (51991-748-10), Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. (D-0583-2026).

Most recent recalls

Questions about this company

Does Breckenridge Pharmaceutical, Inc have recalls in 2026?
Recalert records 3 recalls for Breckenridge Pharmaceutical, Inc dated in 2026.
How do I check if my Breckenridge Pharmaceutical, Inc product is recalled?
Compare the product, model, lot or UPC with the official notices. Check your inventory free on Recalert.

Do you carry products from Breckenridge Pharmaceutical, Inc? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies